ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Microbial Collagenase

Also written as “EN3835”, “Santyl” and “AA4500”.

Its studies are mostly in Cellulite · Penile Induration · Dupuytren Contracture · Diabetic Foot · Bursitis, led by 5 companies.

Drug pageMicrobial Collagenase: every studyMany companies study it; this page follows only the 42 they lead. All 71 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Dec 17, 201142 company-led studies, 2 open or runningNext primary completion: Dec 2027 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Keenova Therapeuticsits history only382 open or runningphase 4since Dec 17, 2011Sep 11, 2007Dec 2027phase 3 · NCT07759362
Advance Biofactures10 open or runningphase 1since Aug 22, 2016Aug 22, 2016none ahead
Asahi Kasei Therapeuticsits history only10 open or runningphase 3since Apr 27, 2012Apr 27, 2012none ahead
Luxurgeryits history only10 open or runningphase 4since Mar 24, 2022Mar 24, 2022none ahead
Manhattan Medical Research Practice, PLLCits history only10 open or runningphase 4since Nov 30, 2018Nov 30, 2018none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Aug 22, 2016First study: phase 1 study in LeiomyomaFirst studyNCT02889848 · 15 enrolled · United States

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

The one study Advance Biofactures leads. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT02889848Leiomyoma · United States1CompletedOct 5, 201815

How it is read

Names in the registry

  • “EN3835”, 9 entries
  • “Santyl”, 7 entries
  • “AA4500”, 7 entries
  • “collagenase clostridium histolyticum”, 5 entries
  • “Collagenase Clostridium Histolyticum”, 5 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.